Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tamiflu DTC Ads Should Encourage Flu Vaccination, FDA's Jolson Suggests

Executive Summary

Direct-to-consumer advertising for Roche/Gilead's Tamiflu should emphasize the importance of influenza vaccination, FDA Antiviral Drug Products Division Director Heidi Jolson, MD, said in a memo explaining FDA's rationale for approving the flu treatment.

You may also be interested in...



Roche Tamiflu Celebrity Endorsement Ad Challenged By FDA

Celebrity endorsements of prescription drugs must be carefully qualified to avoid overstating efficacy, FDA told Roche in a letter objecting to a radio broadcast commercial for the flu therapy Tamiflu (oseltamivir)

Roche Tamiflu Celebrity Endorsement Ad Challenged By FDA

Celebrity endorsements of prescription drugs must be carefully qualified to avoid overstating efficacy, FDA told Roche in a letter objecting to a radio broadcast commercial for the flu therapy Tamiflu (oseltamivir)

Viropharma Picovir Pre-Prescribing Raises Risk Management Issues

Viropharma Picovir studies should address pre-prescribing issues, FDA's Antiviral Drugs Advisory Committee said at its March 19 meeting

Related Content

UsernamePublicRestriction

Register

PS035110

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel